世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Flavored Veterinary Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Flavored Veterinary Medication was estimated to be worth US$ 3573 million in 2024 and is forecast to a readjusted size of US$ 6601 million by 2031 with a CAGR of 9.3% during t... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Flavored Veterinary Medication was estimated to be worth US$ 3573 million in 2024 and is forecast to a readjusted size of US$ 6601 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.Flavored veterinary medication refers to animal medicinal products formulated with specific flavoring agents, taste-masking excipients, or modified dosage forms designed to enhance voluntary intake and treatment adherence, thereby improving clinical outcomes and the medication experience. These products span companion animals (dogs, cats, birds, etc.) and some confined livestock, and include flavored oral tablets, chewables, liquids, suspensions, and feed-mix formulations, both prescription and OTC. Flavoring aims to overcome animals’ innate aversions—bitterness, off-odors or unpleasant textures—by using species-targeted flavors (e.g., meat, fish preferences) and textural optimization to simplify administration, reduce stress, and increase completion rates of therapeutic courses. Beyond flavor addition, modern flavored veterinary medicines emphasize synergy with delivery systems and dosage convenience (chewables, oral pastes, premixed feed), and must comply with strict safety, residue and veterinary regulatory standards to protect both animal and human food-chain safety. Rising pet ownership, pet humanization, and upgraded pet healthcare spending drive demand for flavored veterinary medications as practical solutions to improve adherence, reduce animal stress, and improve therapeutic completion. Corporate annual reports indicate that major animal-health companies are integrating palatability and formulation capabilities into core strategies through product portfolio expansion, M&A and geographic growth; regulatory clarifications on acceptable dosage forms and palatability claims provide clearer compliance pathways. Advances in flavor technology (microencapsulation, controlled release) allow flavor longevity and safety, enabling products suitable for chronic therapies and long-term dosing—making palatability innovation a central growth driver. Key constraints include regulatory scrutiny over permitted flavoring compounds, excipient residues and impacts on human food safety, requiring companies to balance innovation with compliance costs disclosed in annual reports. Flavor-excipient interactions can affect drug stability and bioavailability, necessitating costly compatibility and toxicology studies. Regulatory ambiguity between prescription and compounded products, and tighter oversight on compounding, can disrupt small compounding pharmacies and veterinary compounding models. Finally, competition from established animal-health majors and specialized flavor suppliers can compress margins for smaller players. On the downstream side, demand is shifting from purely functional palatability to context-driven and service-oriented needs: pet owners and veterinarians want convenient administration, stress reduction, and home-care suitability. This drives demand for convenient dosage forms (single-use oral strips, chewables, ready-to-use liquids), diversified flavor portfolios, and tailored solutions for age, breed and preference. Food-safety and public-health considerations also propel the livestock sector to seek safe, mixable flavoring solutions that balance palatability with residue control. Clinical guidelines and strategic commitments in corporate annual reports point to increasing demand for standardized, scalable flavored veterinary products. Key upstream inputs include natural or synthetic flavor compounds, sweeteners and taste-masking agents, textural excipients and binders, as well as carriers and stabilizers compatible with active pharmaceutical ingredients. Challenges include ensuring physicochemical compatibility, stability and toxicological safety of flavor materials with actives; supply risks arise from raw-material variability, supplier concentration and import/export controls (notably for natural extracts). Sustainability and responsible sourcing matter—natural flavor feedstocks can be climate-sensitive, while synthetic alternatives must meet safety and acceptance thresholds. Leading animal-health companies highlight in annual reports the critical importance of supplier qualification, raw-material traceability and GMP-grade excipient sourcing—factors that elevate both cost and market entry barriers.The gross profit margin of this product is around 55%. This report aims to provide a comprehensive presentation of the global market for Flavored Veterinary Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Flavored Veterinary Medication by region & country, by Type, and by Application. The Flavored Veterinary Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flavored Veterinary Medication. Market Segmentation By Company Boehringer Ingelheim Elanco Animal Health Zoetis Merck & Co. Ceva Vetoquinol Wedgewood Pharmacy Virbac BOVA Lee Silsby Compounding Pharmacy Golden Gate China Animal Healthcare Qingdao Yibang Rupu Bio Segment by Type Meat Flavored Fish Flavored Fruit Flavored Others Segment by Application Dogs Cats Other By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Flavored Veterinary Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Revenue of Flavored Veterinary Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Revenue of Flavored Veterinary Medication in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Flavored Veterinary Medication Product Introduction 1.2 Global Flavored Veterinary Medication Market Size Forecast (2020-2031) 1.3 Flavored Veterinary Medication Market Trends & Drivers 1.3.1 Flavored Veterinary Medication Industry Trends 1.3.2 Flavored Veterinary Medication Market Drivers & Opportunity 1.3.3 Flavored Veterinary Medication Market Challenges 1.3.4 Flavored Veterinary Medication Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Flavored Veterinary Medication Players Revenue Ranking (2024) 2.2 Global Flavored Veterinary Medication Revenue by Company (2020-2025) 2.3 Key Companies Flavored Veterinary Medication Manufacturing Base Distribution and Headquarters 2.4 Key Companies Flavored Veterinary Medication Product Offered 2.5 Key Companies Time to Begin Mass Production of Flavored Veterinary Medication 2.6 Flavored Veterinary Medication Market Competitive Analysis 2.6.1 Flavored Veterinary Medication Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Flavored Veterinary Medication Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flavored Veterinary Medication as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Meat Flavored 3.1.2 Fish Flavored 3.1.3 Fruit Flavored 3.1.4 Others 3.2 Global Flavored Veterinary Medication Sales Value by Type 3.2.1 Global Flavored Veterinary Medication Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Flavored Veterinary Medication Sales Value, by Type (2020-2031) 3.2.3 Global Flavored Veterinary Medication Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Dogs 4.1.2 Cats 4.1.3 Other 4.2 Global Flavored Veterinary Medication Sales Value by Application 4.2.1 Global Flavored Veterinary Medication Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Flavored Veterinary Medication Sales Value, by Application (2020-2031) 4.2.3 Global Flavored Veterinary Medication Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Flavored Veterinary Medication Sales Value by Region 5.1.1 Global Flavored Veterinary Medication Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Flavored Veterinary Medication Sales Value by Region (2020-2025) 5.1.3 Global Flavored Veterinary Medication Sales Value by Region (2026-2031) 5.1.4 Global Flavored Veterinary Medication Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Flavored Veterinary Medication Sales Value, 2020-2031 5.2.2 North America Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Flavored Veterinary Medication Sales Value, 2020-2031 5.3.2 Europe Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Flavored Veterinary Medication Sales Value, 2020-2031 5.4.2 Asia Pacific Flavored Veterinary Medication Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Flavored Veterinary Medication Sales Value, 2020-2031 5.5.2 South America Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Flavored Veterinary Medication Sales Value, 2020-2031 5.6.2 Middle East & Africa Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Flavored Veterinary Medication Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Flavored Veterinary Medication Sales Value, 2020-2031 6.3 United States 6.3.1 United States Flavored Veterinary Medication Sales Value, 2020-2031 6.3.2 United States Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Flavored Veterinary Medication Sales Value, 2020-2031 6.4.2 Europe Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Flavored Veterinary Medication Sales Value, 2020-2031 6.5.2 China Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031 6.5.3 China Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Flavored Veterinary Medication Sales Value, 2020-2031 6.6.2 Japan Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Flavored Veterinary Medication Sales Value, 2020-2031 6.7.2 South Korea Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Flavored Veterinary Medication Sales Value, 2020-2031 6.8.2 Southeast Asia Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Flavored Veterinary Medication Sales Value, 2020-2031 6.9.2 India Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031 6.9.3 India Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Boehringer Ingelheim 7.1.1 Boehringer Ingelheim Profile 7.1.2 Boehringer Ingelheim Main Business 7.1.3 Boehringer Ingelheim Flavored Veterinary Medication Products, Services and Solutions 7.1.4 Boehringer Ingelheim Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.1.5 Boehringer Ingelheim Recent Developments 7.2 Elanco Animal Health 7.2.1 Elanco Animal Health Profile 7.2.2 Elanco Animal Health Main Business 7.2.3 Elanco Animal Health Flavored Veterinary Medication Products, Services and Solutions 7.2.4 Elanco Animal Health Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.2.5 Elanco Animal Health Recent Developments 7.3 Zoetis 7.3.1 Zoetis Profile 7.3.2 Zoetis Main Business 7.3.3 Zoetis Flavored Veterinary Medication Products, Services and Solutions 7.3.4 Zoetis Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.3.5 Zoetis Recent Developments 7.4 Merck & Co. 7.4.1 Merck & Co. Profile 7.4.2 Merck & Co. Main Business 7.4.3 Merck & Co. Flavored Veterinary Medication Products, Services and Solutions 7.4.4 Merck & Co. Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.4.5 Merck & Co. Recent Developments 7.5 Ceva 7.5.1 Ceva Profile 7.5.2 Ceva Main Business 7.5.3 Ceva Flavored Veterinary Medication Products, Services and Solutions 7.5.4 Ceva Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.5.5 Ceva Recent Developments 7.6 Vetoquinol 7.6.1 Vetoquinol Profile 7.6.2 Vetoquinol Main Business 7.6.3 Vetoquinol Flavored Veterinary Medication Products, Services and Solutions 7.6.4 Vetoquinol Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.6.5 Vetoquinol Recent Developments 7.7 Wedgewood Pharmacy 7.7.1 Wedgewood Pharmacy Profile 7.7.2 Wedgewood Pharmacy Main Business 7.7.3 Wedgewood Pharmacy Flavored Veterinary Medication Products, Services and Solutions 7.7.4 Wedgewood Pharmacy Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.7.5 Wedgewood Pharmacy Recent Developments 7.8 Virbac 7.8.1 Virbac Profile 7.8.2 Virbac Main Business 7.8.3 Virbac Flavored Veterinary Medication Products, Services and Solutions 7.8.4 Virbac Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.8.5 Virbac Recent Developments 7.9 BOVA 7.9.1 BOVA Profile 7.9.2 BOVA Main Business 7.9.3 BOVA Flavored Veterinary Medication Products, Services and Solutions 7.9.4 BOVA Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.9.5 BOVA Recent Developments 7.10 Lee Silsby Compounding Pharmacy 7.10.1 Lee Silsby Compounding Pharmacy Profile 7.10.2 Lee Silsby Compounding Pharmacy Main Business 7.10.3 Lee Silsby Compounding Pharmacy Flavored Veterinary Medication Products, Services and Solutions 7.10.4 Lee Silsby Compounding Pharmacy Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.10.5 Lee Silsby Compounding Pharmacy Recent Developments 7.11 Golden Gate 7.11.1 Golden Gate Profile 7.11.2 Golden Gate Main Business 7.11.3 Golden Gate Flavored Veterinary Medication Products, Services and Solutions 7.11.4 Golden Gate Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.11.5 Golden Gate Recent Developments 7.12 China Animal Healthcare 7.12.1 China Animal Healthcare Profile 7.12.2 China Animal Healthcare Main Business 7.12.3 China Animal Healthcare Flavored Veterinary Medication Products, Services and Solutions 7.12.4 China Animal Healthcare Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.12.5 China Animal Healthcare Recent Developments 7.13 Qingdao Yibang 7.13.1 Qingdao Yibang Profile 7.13.2 Qingdao Yibang Main Business 7.13.3 Qingdao Yibang Flavored Veterinary Medication Products, Services and Solutions 7.13.4 Qingdao Yibang Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.13.5 Qingdao Yibang Recent Developments 7.14 Rupu Bio 7.14.1 Rupu Bio Profile 7.14.2 Rupu Bio Main Business 7.14.3 Rupu Bio Flavored Veterinary Medication Products, Services and Solutions 7.14.4 Rupu Bio Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025) 7.14.5 Rupu Bio Recent Developments 8 Industry Chain Analysis 8.1 Flavored Veterinary Medication Industrial Chain 8.2 Flavored Veterinary Medication Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Flavored Veterinary Medication Sales Model 8.5.2 Sales Channel 8.5.3 Flavored Veterinary Medication Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の 医薬・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（flavored）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
